Navigation Links
New treatment for lung cancer shows promise
Date:11/15/2010

Arlington, Va. A new inhalable dry powder treatment for lung cancer shows a significant increase in survival rates and is far less invasive than current treatment options, which frequently include radiation and surgery. This research is being presented at the 2010 International Pharmaceutical Federation (FIP) Pharmaceutical Sciences World Congress (PSWC) in association with the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition in New Orleans, La., Nov. 14-18.

Lung cancer is the second most common type of cancer in the U.S., accounting for more deaths than breast, prostate and colon cancer combined, according to the Centers for Disease Control and Prevention. Many people endure more than one type of lung cancer treatment, which can last for weeks to months.

Lead researcher Raimar Lbenberg and his colleagues Warren Finlay and Wilson Roa from the University of Alberta developed an inhalable dry powder using a common chemotherapy drug encapsulated into nanoparticles. Some mice were treated with the inhalable powder and others with the same drug through two different delivery methods, a solution and IV injection of drug bound nanoparticles.

Results showed that the inhalable dry powder was more effective than using the IV or solution. In the study, more than 80 percent of the mice survived for more than 90 days and more than 70 percent survived for 140 days. None of the mice treated with the IV injection or solution survived past 50 days.

"Current lung cancer treatments can be grueling and take a significant toll on the patient," said Lbenberg. "Our results show that this treatment method may not only increase someone's survival rate but could also potentially be less toxic to the body."

The inhalable dry powder was also more effective than the IV injection in reducing the amount and size of tumors. Large tumor masses were seen in the lungs of those animals that were not treated or treated with the IV injection or solution. Animals treated with the inhalable dry powder showed fewer and much smaller tumors.


'/>"/>

Contact: Joseph Catapano
catapanoj@aaps.org
703-248-4772
American Association of Pharmaceutical Scientists
Source:Eurekalert

Related medicine news :

1. Prostate cancer treatment linked to higher rate of colon cancer, study finds
2. Social Class May Affect Outcome of Depression Treatment
3. Could a Prostate Cancer Treatment Raise Colon Cancer Risk?
4. Side effects of hormonal breast cancer therapy increased; may affect treatment adherence
5. Study shows durable viral suppression of boosted REYATAZ in treatment-experienced HIV patients
6. Cheaper, Older Treatment for Vasculitis Beats Out New Drug
7. Major clinical trial prompts call for change to treatment guidelines for severe malaria worldwide
8. Lupus Kidney Disorder Treatment Improved Over Decade: Review
9. Treatment trends for biceps injuries
10. Experts issue recommendations for treatment of post-bariatric surgery patients
11. Use of Prostate Cancer Treatment Fell When Medicare Paid Docs Less
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... , ... May 27, 2016 , ... Two director-level employees ... YWCA Tribute to Women and Industry (TWIN) 2016 honorees. The award recognizes businesswomen ... For this year, Geri Boone, Director of the MLTSS (Managed Long-Term Services and Supports) ...
(Date:5/27/2016)... ... ... An influential resource amongst nurses and professionals in the health care world, ... of topics detailing why we appreciate nurses in so many different ways. From exclusive ... being in a major recession to one of the hottest growing professions in any ...
(Date:5/27/2016)... New York, NY (PRWEB) , ... May 27, 2016 , ... ... the factors of a stroke, which we as a society can control and change. ... a stroke occurs nearly every 40 seconds within the United States. Plus, with an ...
(Date:5/27/2016)... , ... May 27, 2016 , ... ... to help educate the many who are unaware of the plight of aphasia. ... will run within the “Stroke Awareness” campaign. , The link between stroke and ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and ... interest stories, courtesy of leaders in the nursing and health care industry. It ... leading advocates and associations—namely Jones & Bartlett Learning. , Jones & Bartlett Learning ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... 2016  Granger Diagnostics today announced immediate availability of ... infections. This test ensures discovery of ALL bacteria, ... test requires only a simple swab of the wound ... G. Bostwick , MD, Chief Medical Officer, described ... "We are excited to make available, for the ...
(Date:5/25/2016)... , May 25, 2016 MedDay, ... disorders, announces that an oral presentation entitled "High doses of ... MS-SPI trial" will be given by Professor Ayman Tourbah ... 2nd Congress of the European Academy of Neurology (EAN) in ... and related disorders 3" will take place on Sunday, 29 ...
(Date:5/25/2016)... ReportsnReports.com adds "Chronic Cough ... provides an overview on therapeutic pipeline of Chronic ... therapeutics assessment by drug target, mechanism of action ... along with latest updates, and featured news and ... in the therapeutic development for Chronic Cough and ...
Breaking Medicine Technology: